Actelion Pharmaceuticals Ltd

Actelion Pharmaceuticals Ltd is a company in Allschwil, Switzerland that has taken part in 6 EU-funded projects since 2008, receiving €248k in EU funding.

EU funding received€248k
EU projects6
As coordinator0
Running now3
First EU project2008
Latest project2026
CountrySwitzerland
EU registration (PIC)999812466
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Actelion Pharmaceuticals Ltd's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€248k · 1 project
  • Horizon Europe€0 · 3 projects
  • Horizon 2020€0 · 2 projects

Projects

6 EU-funded projects, newest first. Each links to the official record.

  • FORTIFYAssociated partner

    FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

  • GREGAssociated partner

    Testing, improving, and co-creating Guidance and Tools for Real World Evidence Generation in Europe and use for Decision-Making in Europe: GREG

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

  • UMBRELLAAssociated partner

    Unleashing a CoMprehensive, Holistic and Patient Centric Stroke Management for a Better, Rapid, AdvancEd and PersonaLised Stroke Diagnosis, TreAtment and Outcome Prediction

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

  • PREFERPartner

    Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966

    Horizon 2020 · 2016–2022 · Project on CORDIS ↗

  • ONCORNETPartner

    ONCOgenic Receptor Network of Excellence and Training

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

  • TUMICPartner

    An integrated concept of tumor metastasis: implications for therapy

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €248ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA viruses
  • data processing
  • data protection
  • drug discovery
  • entrepreneurship
  • governance
  • oncology
  • pharmaceutical drugs
  • physiotherapy
  • proteomics
  • stem cells
  • stroke

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime